JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/28 | 6,270 | 6,280 | 6,020 | 6,180 | -120 | -1.9% | 149,200 |
2019/02/27 | 6,220 | 6,370 | 6,120 | 6,300 | +70 | +1.1% | 191,500 |
2019/02/26 | 6,040 | 6,230 | 5,970 | 6,230 | +210 | +3.5% | 153,400 |
2019/02/25 | 5,970 | 6,070 | 5,940 | 6,020 | +50 | +0.8% | 65,600 |
2019/02/22 | 5,980 | 6,030 | 5,920 | 5,970 | -20 | -0.3% | 130,700 |
2019/02/21 | 5,740 | 6,010 | 5,720 | 5,990 | +290 | +5.1% | 138,900 |
2019/02/20 | 5,810 | 5,810 | 5,670 | 5,700 | -80 | -1.4% | 46,300 |
2019/02/19 | 5,750 | 5,800 | 5,700 | 5,780 | +30 | +0.5% | 43,500 |
2019/02/18 | 5,800 | 5,820 | 5,650 | 5,750 | +140 | +2.5% | 68,200 |
2019/02/15 | 5,690 | 5,710 | 5,600 | 5,610 | -140 | -2.4% | 71,600 |
2019/02/14 | 5,800 | 5,850 | 5,700 | 5,750 | -50 | -0.9% | 65,400 |
2019/02/13 | 5,850 | 5,890 | 5,770 | 5,800 | -20 | -0.3% | 82,300 |
2019/02/12 | 5,660 | 5,860 | 5,660 | 5,820 | +160 | +2.8% | 75,200 |
2019/02/08 | 5,730 | 5,780 | 5,600 | 5,660 | -140 | -2.4% | 83,100 |
2019/02/07 | 5,830 | 5,860 | 5,740 | 5,800 | -30 | -0.5% | 51,900 |
2019/02/06 | 5,910 | 5,980 | 5,800 | 5,830 | -20 | -0.3% | 106,600 |
2019/02/05 | 6,000 | 6,010 | 5,790 | 5,850 | -110 | -1.8% | 116,900 |
2019/02/04 | 5,690 | 6,140 | 5,690 | 5,960 | +320 | +5.7% | 260,400 |
2019/02/01 | 5,410 | 5,670 | 5,230 | 5,640 | ±0 | ±0% | 311,700 |
2019/01/31 | 5,600 | 5,710 | 5,600 | 5,640 | +80 | +1.4% | 160,600 |
2019/01/30 | 5,740 | 5,870 | 5,350 | 5,560 | -470 | -7.8% | 389,100 |
2019/01/29 | 5,990 | 6,060 | 5,920 | 6,030 | +20 | +0.3% | 134,400 |
2019/01/28 | 6,170 | 6,220 | 6,010 | 6,010 | -120 | -2% | 126,600 |
2019/01/25 | 6,020 | 6,270 | 5,990 | 6,130 | +70 | +1.2% | 152,700 |
2019/01/24 | 6,080 | 6,190 | 6,020 | 6,060 | -20 | -0.3% | 118,000 |
2019/01/23 | 5,870 | 6,170 | 5,860 | 6,080 | +110 | +1.8% | 182,000 |
2019/01/22 | 5,840 | 6,010 | 5,780 | 5,970 | +120 | +2.1% | 144,600 |
2019/01/21 | 6,200 | 6,270 | 5,820 | 5,850 | -300 | -4.9% | 199,700 |
2019/01/18 | 6,010 | 6,230 | 5,900 | 6,150 | +140 | +2.3% | 265,100 |
2019/01/17 | 5,930 | 6,030 | 5,830 | 6,010 | +140 | +2.4% | 235,200 |
2019/01/16 | 5,850 | 5,970 | 5,770 | 5,870 | +120 | +2.1% | 181,500 |
2019/01/15 | 5,620 | 5,850 | 5,560 | 5,750 | +50 | +0.9% | 168,800 |
2019/01/11 | 5,550 | 5,740 | 5,490 | 5,700 | +130 | +2.3% | 258,400 |
2019/01/10 | 5,590 | 5,800 | 5,550 | 5,570 | +50 | +0.9% | 347,800 |
2019/01/09 | 5,150 | 5,670 | 5,150 | 5,520 | +440 | +8.7% | 285,800 |
2019/01/08 | 4,985 | 5,200 | 4,985 | 5,080 | +105 | +2.1% | 159,100 |
2019/01/07 | 4,995 | 5,090 | 4,930 | 4,975 | +250 | +5.3% | 133,000 |
2019/01/04 | 4,445 | 4,780 | 4,445 | 4,725 | +70 | +1.5% | 123,300 |
2018/12/28 | 4,665 | 4,730 | 4,575 | 4,655 | -80 | -1.7% | 81,800 |
2018/12/27 | 4,665 | 4,805 | 4,535 | 4,735 | +395 | +9.1% | 103,000 |
2018/12/26 | 4,365 | 4,450 | 4,260 | 4,340 | +45 | +1% | 96,100 |
2018/12/25 | 4,445 | 4,485 | 4,275 | 4,295 | -500 | -10.4% | 161,800 |
2018/12/21 | 4,920 | 4,995 | 4,685 | 4,795 | -165 | -3.3% | 139,700 |
2018/12/20 | 5,150 | 5,150 | 4,875 | 4,960 | -320 | -6.1% | 191,500 |
2018/12/19 | 5,200 | 5,380 | 5,110 | 5,280 | +30 | +0.6% | 110,700 |
2018/12/18 | 5,300 | 5,420 | 5,250 | 5,250 | -240 | -4.4% | 88,100 |
2018/12/17 | 5,430 | 5,560 | 5,350 | 5,490 | +60 | +1.1% | 80,900 |
2018/12/14 | 5,580 | 5,650 | 5,410 | 5,430 | -230 | -4.1% | 122,000 |
2018/12/13 | 5,600 | 5,760 | 5,570 | 5,660 | +160 | +2.9% | 139,000 |
2018/12/12 | 5,310 | 5,530 | 5,240 | 5,500 | +280 | +5.4% | 113,000 |
1401~
1450
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム